Cargando…
COVID-19, Obesity, and GRP78: Unraveling the Pathological Link
The coronavirus disease 2019 (COVID-19) pandemic, driven by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented global surge in infections and fatalities. Notably, obesity has emerged as an important susceptibility factor for COVID-19; however, the pathological...
Autores principales: | Shin, Jihoon, Shimomura, Iichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583770/ https://www.ncbi.nlm.nih.gov/pubmed/37752707 http://dx.doi.org/10.7570/jomes23053 |
Ejemplares similares
-
GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors
por: Shin, Jihoon, et al.
Publicado: (2022) -
Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19
por: Shin, Jihoon, et al.
Publicado: (2021) -
COVID19 associated mucormycosis: Is GRP78 a possible link?
por: Gumashta, Jyotsna, et al.
Publicado: (2021) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021) -
GRP78 Activity Moderation as a Therapeutic Treatment against Obesity
por: Pan, Dongjin, et al.
Publicado: (2022)